ClinicalTrials.gg
BiologicalDrug

Alpha 1-Antitrypsin clinical trials

Also written Alpha1-Proteinase Inhibitor, Prolastin-C, Zemaira and BAY 10-5233.

studies test it
50
open now
4
in phase 3
14
first study started
2003

How each study uses alpha 1-Antitrypsin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the alpha 1-Antitrypsin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
2 Dec 1987 · prolastin,prolastin-c,prolastin-c liquid · BLA 103174 (FDA, Purple Book)
European Union
20 Aug 2015 · Respreeza · EMEA/H/C/002739 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Aralast NP
9
Alpha-1 MP
7
Alpha 1-Antitrypsin
7
AAT
7
Alpha-1 antitrypsin (AAT)
5

Brand

Prolastin-C
8
Zemaira
7
Prolastin
6
GLASSIA
5

Development codes

BAY 10-5233
3
TAL-05-00007
3
TAK-883
2
TAL6004
1
CE1226
1

Other names

Alpha1-Proteinase Inhibitor
10
Alpha1-Proteinase Inhibitor (Human)
5
Alpha-1 proteinase inhibitor (human)
2
Human alpha1-proteinase inhibitor
1
Alfa1 Antitrypsin
1

Studies by the year they started

50 studies that test it; most in 2014 (6)

Studies that test alpha 1-Antitrypsin, by start year
YearStudies
20032
20041
20065
20104
20112
20124
20134
20146
20151
20166
20173
20181
20192
20202
20212
20221
20241
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
11
Phase 2
30
Phase 3
14
Phase 4
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 27 · Other 23

Grifols Therapeutics LLC (12) · Baxalta now part of Shire (5) · CSL Behring (4) · Kamada, Ltd. (3) · Institute for Human Genetics and Biochemistry (2) · Rabin Medical Center (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · University of Minnesota (1)

Often tested with

Tested in the same studies.

Etanercept (2) · Thymoglobulin (1) · Basiliximab (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test alpha 1-Antitrypsin.

Studies

Open first, then newest update. How each study uses alpha 1-Antitrypsin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 50

See all 50 studies that test alpha 1-Antitrypsin →

As the comparator · 2 — what is tested is compared with alpha 1-Antitrypsin

Codes

What other systems call alpha 1-Antitrypsin · ClinicalTrials.gg INT006929

  • MeSH (NLM) D000515alpha 1-AntitrypsinOne source ClinicalTrials.gov
  • RxNorm 991743One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.